The clinical value of PD-L1 status as predictive biomarker in first-line treatment of urothelial carcinoma of the bladder

被引：0
|
作者：
Tamalunas, A. [1 ]
Schott, M. [1 ]
Rodler, S. [1 ]
Stief, C. G. [1 ]
Casuscelli, J. [1 ]
机构：
[1] Univ Hosp Munich, Dept Urol, Munich, Germany
来源：
EUROPEAN UROLOGY | 2022年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A1065
引用
收藏
页码：S1570 / S1570
页数：1
相关论文
共 50 条
  • [31] Immune Checkpoint Inhibitors in Urothelial Carcinoma: Recommendations for Practical Approaches to PD-L1 and Other Potential Predictive Biomarker Testing
    Lopez-Beltran, Antonio
    Lopez-Rios, Fernando
    Montironi, Rodolfo
    Wildsmith, Sophie
    Eckstein, Markus
    CANCERS, 2021, 13 (06) : 1 - 18
  • [32] The clinicopathological and prognostic value of PD-L1 in urothelial carcinoma: a meta-analysis
    Wen, Yaoan
    Chen, Yeda
    Duan, Xiaolu
    Zhu, Wei
    Cai, Chao
    Deng, Tuo
    Zeng, Guohua
    CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 19 (04) : 407 - 416
  • [33] The clinicopathological and prognostic value of PD-L1 in urothelial carcinoma: a meta-analysis
    Yaoan Wen
    Yeda Chen
    Xiaolu Duan
    Wei Zhu
    Chao Cai
    Tuo Deng
    Guohua Zeng
    Clinical and Experimental Medicine, 2019, 19 : 407 - 416
  • [34] Clinicopathological and prognostic value of PD-L1 in urothelial carcinoma: a meta-analysis
    Ding, Xiangli
    Chen, Qiaochao
    Yang, Zhao
    Li, Jun
    Zhan, Hui
    Lu, Nihong
    Chen, Min
    Yang, Yanlong
    Wang, Jiansong
    Yang, Delin
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 4171 - 4184
  • [35] The efficacy and safety of chemotherapy with or without anti-PD-1 for the first-line treatment of advanced urothelial carcinoma
    Han, Fuxin
    Wu, Zhaozhen
    Chen, Jiaxin
    Liu, Meicen
    Hu, Yi
    CANCER MEDICINE, 2023, 12 (23): : 21129 - 21137
  • [36] Prognostic value of PD-L1 status
    Thoma, Clemens
    NATURE REVIEWS UROLOGY, 2016, 13 (12) : 694 - 694
  • [37] Prognostic value of PD-L1 status
    Clemens Thoma
    Nature Reviews Urology, 2016, 13 : 694 - 694
  • [38] Research progress on PD-1 and PD-L1 inhibitors in the treatment of metastatic urothelial carcinoma
    Tang, Quanqing
    Li, Shihao
    Huang, Gaozhen
    Liu, Hongwei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 119
  • [39] PD-L1 Expression and Associated Immune Alterations in High Grade Urothelial Carcinoma of the Bladder
    Olkhov-Mitsel, Ekaterina
    Hodgson, Anjelica
    Liu, Stanley
    Vesprini, Danny
    Bayani, Jane
    Bartlett, John
    Xu, Bin
    Downes, Michelle
    MODERN PATHOLOGY, 2019, 32
  • [40] PD-L1 Expression and Associated Immune Alterations in High Grade Urothelial Carcinoma of the Bladder
    Olkhov-Mitsel, Ekaterina
    Hodgson, Anjelica
    Liu, Stanley
    Vesprini, Danny
    Bayani, Jane
    Bartlett, John
    Xu, Bin
    Downes, Michelle
    LABORATORY INVESTIGATION, 2019, 99
12345